March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Christine Hodgdon: CHLOE study enrolling participants with HER2+ oligometastatic breast cancer
Mar 16, 2025, 12:18

Christine Hodgdon: CHLOE study enrolling participants with HER2+ oligometastatic breast cancer

Christine Hodgdon, Co-founder of GRASP, shared a post on X:

“If you are living with HER2+ oligometastatic breast cancer (oligo = limited of mets), you may be eligible to participate in the CHLOE study, Yale Cancer Center.

Individuals (US and international) can now self refer!

Read more.”

More posts featuring Christine Hodgdon.